This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Posted on 18 April 2018 | 8:39 pm
ASLAN Pharmaceuticals Updates US IPO Plans -
ASLAN Pharmaceuticals Updates US IPO PlansSeeking AlphaPrior to ASLAN Pharmaceuticals, Firth was the Director, Head of Asia Healthcare of Merrill Lynch from 2008 - 2010. Firth also served as the Regional Business Development & Strategic Planning Director, AsiaPac of AstraZeneca (AZN) from January 2007 ...
Posted on 18 April 2018 | 2:50 pm
Rigel Pharmaceuticals (RIGL) FDA Approval Of
Seeking AlphaRigel Pharmaceuticals (RIGL) FDA Approval Of TAVALISSE(TM) - SlideshowSeeking AlphaRigel Pharmaceuticals (RIGL) FDA Approval Of TAVALISSE(TM) - Slideshow. Apr.18.18 | About: Rigel Pharmaceuticals, (RIGL). The following slide deck was published by Rigel Pharmaceuticals, Inc. in conjunction with this event. 123. Conference Call April ...
Posted on 18 April 2018 | 2:28 pm
BRIEF-Intracoastal Capital LLC Reports 9.2
BRIEF-Intracoastal Capital LLC Reports 9.2 Pct Passive Stake In RXI Pharmaceuticals Corp, As Of April 9ReutersBRIEF-Intracoastal Capital LLC Reports 9.2 Pct Passive Stake In RXI Pharmaceuticals Corp, As Of April 9. Reuters Staff. 1 Min Read. April 18 (Reuters) - Rxi Pharmaceuticals Corp: * INTRACOASTAL CAPITAL LLC REPORTS 9.2 PERCENT PASSIVE STAKE IN RXI ...
Posted on 18 April 2018 | 2:05 pm
Cannabics Pharmaceuticals gains new
Cannabics Pharmaceuticals gains new technology patentMaryland Daily RecordCannabics Pharmaceuticals gains new technology patent. By: Daily Record Staff April 18, 2018. Bethesda-based Cannabics Pharmaceuticals Inc., a company involved in cannabinoid diagnostics for the personalized treatment of cancer, announced Wednesday the ...and more »
Posted on 18 April 2018 | 1:52 pm
NovaBay Pharmaceuticals to Offer Educational
At the April 19 workshop and dinner, nationally prominent eye experts will describe improvements in lid hygiene regimens made possible by NovaBay's Avenova lid cleanser EMERYVILLE, CA / ACCESSWIRE / April ...
Posted on 10 April 2015 | 9:25 am
Adamas Pharmaceuticals Receives Orphan Drug
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that the Food and Drug Administration (FDA) has granted orphan drug status to ADS-5102 for the treatment of levodopa-induced dyskinesia ...
Posted on 10 April 2015 | 5:30 am
Reata Pharmaceuticals Receives Orphan Drug
Reata Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of breakthrough medicines for difficult-to-treat diseases, today announced that the FDA Office of Orphan Products Development ...
Posted on 10 April 2015 | 4:30 am
Tokai Pharmaceuticals to Present at Upcoming
Tokai Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases
Posted on 10 April 2015 | 4:00 am
Adamas Pharmaceuticals to Present at 2015
EMERYVILLE, Calif. -- Adamas Pharmaceuticals, Inc. today announced that Gregory T. Went, PhD., Chief Executive Officer, will present at the 2015 Needham Healthcare Conference in New York on Tuesday, April ...
Posted on 9 April 2015 | 1:01 pm
Amgen wins approval for second biotech
Sanofi and partner Regeneron Pharmaceuticals Inc. won FDA approval for that drug last month. Analysts estimate between 8 million to 10 million patients are covered under the FDA-approved labeling for the drugs. But some experts worry the drugs could ...
Posted on 27 August 2015 | 10:18 pm
Singapore manufacturing falls 6.1%
SINGAPORE: The Republic's industrial production fell year-on-year for the sixth straight month in July, hurt by lower output of electronics, pharmaceuticals and rigs, EDB reported on Wednesday (Aug 26). Production in the electronics cluster fell 5.8 per ...
Posted on 27 August 2015 | 9:52 pm
New Data on Actelion Pulmonary Arterial
Actelion Pharmaceuticals Ltd recently announced in a press release that new data on its investigational drug selexipag (Uptravi®) and the approved macitentan (Opsumit®) for pulmonary arterial hypertension will be presented at the upcoming European ...
Posted on 27 August 2015 | 9:45 pm
Teva Pharmaceutical Industries Ltd (ADR) Not
Teva has successfully switched patients to the 3x/week (40mg) from the once/daily (20mg)…” Teva continues to face generic competition on its once/daily (20mg) regimen from Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) and Sandoz, the generic drug unit of ...
Posted on 27 August 2015 | 9:12 pm
ACADIA Pharmaceuticals Stock Rating
ACADIA Pharmaceuticals (NASDAQ:ACAD)‘s stock had its “outperform” rating reaffirmed by Cowen and Company in a note issued to investors on Friday, MarketBeat reports. They currently have a $50.00 price target on the biopharmaceutical company’s stock.
Posted on 27 August 2015 | 8:43 pm
NJ drug company execs charged with insider
Executives at two leading drug companies were among six people arrested Monday and charged with insider trading in what federal prosecutors said was a five-year-long scheme that netted more than $1 million.
Posted on 19 November 2012 | 10:46 am
AG: J&J must pay $52M in Pa. drug pricing
Johnson & Johnson must pay $52 million in damages and penalties after a Pennsylvania judge found the pharmaceutical company falsely reported the prices of its drugs.
Posted on 17 December 2010 | 3:19 pm
Pfizer will buy King Pharmaceuticals for
Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Posted on 11 October 2010 | 5:12 pm
Endo Pharma paying $1.2 billion for
Drug developer Endo Pharmaceuticals Holdings Inc. said Tuesday it is buying Qualitest Pharmaceuticals for $1.2 billion in a move to diversify its business and strengthen its position in the generic and pain drug markets.
Posted on 28 September 2010 | 3:22 am
Teva plans to appeal lawsuit verdict
Drugmaker Teva Pharmaceutical Industries Ltd. plans to appeal a $356 million Las Vegas district court verdict awarded to a plaintiff who says he contracted hepatitis C when one of Teva's drug vials was used by more than one patient.
Posted on 8 May 2010 | 8:56 am